Back to search

Article

OLFML2B is a Prognostic Biomarker in Lung Adenocarcinoma and Squamous Cell Carcinoma

2021-07-07

Abstract excerpt

<h4>Objective: </h4> The olfactomedin (OLF) and olfactomedin-like (OLFML) domain family consists of at least four members, including OLFML2B, which promotes the EMT, metastasis and invasion of cancer. However, the function of OLFML2B in lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) remains unclear. The aim of this study was to clarify the clinical significance of OLFML2B in LUAD and LUSC. <h4>Metho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8055ddd-5afe-5365-a004-533391d15fd1
DOI
10.21203/rs.3.rs-645819/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
OLFML2B is a Prognostic Biomarker in Lung Adenocarcinoma and Squamous Cell CarcinomaDOI 10.21203/rs.3.rs-645819/v1
Select a neighboring publication to make it the new centre.